Contributed photo
Contributed photo
U.S. Sen. Mark Kirk (R-IL) visited Chicago’s health care technology incubator MATTER late last week to discuss the future of health care innovation with company executives, entrepreneurs and industry leaders.
“From the invention of the cell phone to the zipper, Illinois has long been a center of innovation,” Kirk said. “MATTER’s elevation of our entrepreneurs, startups and industry leaders is a reason why Chicago stands among the global players of health care innovation.”
During his visit, Kirk met with Steven Collens, CEO of MATTER; Jeff Aronin, co-chairman of MATTER and CEO of Marathon Pharmaceuticals; and representatives from AbbVie, Astellas Pharma and BlueCross BlueShield of Illinois to discuss MATTER’s efforts to support the success of next-generation health technology startups.
Kirk also met with some of the entrepreneurs working at MATTER to learn more about their work to create innovative health care solutions.
“MATTER is honored to host Senator Kirk and discuss how entrepreneurs are working to build the future of health care here in Chicago,” Collens said. “We’re grateful for Senator Kirk’s commitment to supporting business growth and healthcare innovation, and we look forward to working with him as MATTER continues to grow.”
Alerts Sign-up